SPL 2.00% 9.8¢ starpharma holdings limited

Ann: DEP HER2-radiodiagnostic shows imaging benefits, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,453 Posts.
    lightbulb Created with Sketch. 580
    Reality check Johnno
    Check the progress of RADs Privilate diagnostic product for an area of high unmet need in brain METS
    With positive Ph2 results published and positive meeting with the FDA as to next steps the CEO has stated that they are 18-24 months from potential commercial product if all goes well.

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.